Clover Health Reports Q3 2026 Profitability and Significant Revenue Growth
Clover Health (CLOV) reported strong third-quarter 2026 financial results, highlighted by a shift to GAAP net income of $6.4 million, compared to a loss in the prior year period. The company saw total revenue climb 53% year-over-year to $759.3 million, fueled primarily by a 45% increase in Medicare Advantage membership, which reached 158,907 members. Management provided optimistic full-year guidance, projecting annual revenue between $2.97 billion and $3.00 billion and forecasting the company's first year of full GAAP profitability with net income expected between $25 million and $35 million. While outpatient utilization remains elevated, it is currently tracking in line with management's previous outlook.
Topics: Financial Guidance Medicare Advantage Profitability Revenue Growth